
Albumedix Is Now Part Of Sartorius
Find high-quality animal and human-origin-free recombinant human albumins in the Recombumin ® product portfolio. Established in the UK in 1984, Albumedix, now a part of Sartorius, has supported its life science partners to deliver hundreds of millions of doses of clinical and marketed therapeutics, globally.
Sartorius to acquire Albumedix, strengthening its portfolio of ...
2022年8月8日 · The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100 percent of Albumedix Ltd. from private investors. The Nottingham, UK-based company provides best-in-class recombinant albumin-based solutions.
Recombinant Human Albumin - Sartorius
Sartorius Albumedix recombinant albumins provide high purity and consistency, offering a multifunctional ancillary, excipient and raw material that delivers dependable performance. View Products Request Your Sample. Learn how high-quality raw materials simplify the journey of cardiomyocyte therapies from lab to clinical trials.
赛多利斯收购Albumedix,创新产品赋能先进疗法
2022年8月8日 · Albumedix将并入赛多利斯生物工艺解决方案板块,其诺丁汉现有的72,000平方英尺的场地将建成为创新中心以及符合GMP要求的关键原材料生产的卓越中心。 Milbank LLP在本次交易中为赛多利斯提供法律咨询服务。
Sartorius to acquire UK’s Albumedix for $501.5m
2022年8月9日 · Life science group Sartorius has signed a definitive agreement for the acquisition of complete outstanding shares of UK-based company Albumedix from private investors in a deal valued at nearly $501.5m (£415m).
Sartorius to acquire Albumedix, creating a powerhouse for …
2022年8月9日 · Albumedix' solutions include the world's only USP-NF compliant recombinant human albumin (Recombumin®), client-centric development and compliance services and drug-enhancing...
Sartorius completes acquisition of Albumedix
2022年9月30日 · The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has successfully closed the acquisition of Albumedix Ltd. as of September 30, 2022. Albumedix is a leader in the field of recombinant albumin-based solutions and based in Nottingham, UK.
Albumedix - Crunchbase Company Profile & Funding
Albumedix is a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilizing our albumin-based drug enhancing technologies. They partner with excellence to improve therapies for people with serious diseases.
Sartorius to acquire Albumedix, strengthening its portfolio of ...
GÖTTINGEN, Germany, Aug. 8, 2022 /PRNewswire/ -- The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100 percent of Albumedix Ltd....
4.15亿英镑!赛多利斯收购重组白蛋白公司Albumedix医药新闻-By…
2022年8月9日 · Albumedix总部位于英国诺丁汉,被公认为重组人白蛋白产品和技术的全球领导者。 重组人白蛋白是生物制药行业各种应用所需的重要成分,例如作为细胞培养基的无动物添加剂以及用于稳定疫苗和病毒疗法。